The DOI matches its Crossref record; 138 of the 138 references it cites were found in a registry or an index.
Targeting STAT3 affects melanoma on multiple fronts
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Vogelstein, B., Lane, D., & Levine, A. J. (2000) · Nature · doi:10.1038/35042675 · Cited by 6,607 · cited 1×
“In addition to Rb pathway regulating progression into the cell cycle, p53 protein is considered to be the most widespread inhibitor of cell proliferation and inducer of apoptosis [77].”
BackgroundDarnell, J. E., Kerr, L. M., & Stark, G. R. (1994) · Science · doi:10.1126/science.8197455 · Cited by 6,080
Cancer immunoediting: from immunosurveillance to tumor escape
Dunn, G. P., Bruce, A. T., Ikeda, H., Old, L. J., & Schreiber, R. D. (2002) · Nature Immunology · doi:10.1038/ni1102-991 · Cited by 5,393
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,531
HOW CELLS RESPOND TO INTERFERONS
Stark, G. R., Kerr, I. M., Williams, B. R. G., Silverman, R. H., & Schreiber, R. D. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.227 · Cited by 3,932
Principles of interleukin (IL)-6-type cytokine signalling and its regulation
HEINRICH, P. C., BEHRMANN, I., HAAN, S., HERMANNS, H. M., MÜLLER-NEWEN, G., & SCHAPER, F. (2003) · Biochemical Journal · doi:10.1042/bj20030407 · Cited by 3,272 · cited 1×
“These include dephosphorylation of the receptor complex or nuclear STAT dimers by protein tyrosine phosphatases (PTPases), interaction of activated STATs with inhibitory molecules from the protein inhibitors of activated STAT (PIAS) family, and feedback inhibition of the JAK/STAT pathway by suppressor of cytokine sign…”
BackgroundIFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity
Shankaran, V., Ikeda, H., Bruce, A. T., White, J. M., Swanson, P. E., Old, L. J., & Schreiber, R. D. (2001) · Nature · doi:10.1038/35074122 · Cited by 2,896
Bromberg, J. F., Wrzeszczynska, M. H., Devgan, G., Zhao, Y., Pestell, R. G., Albanese, C., & Darnell, J. E. (1999) · Cell · doi:10.1016/s0092-8674(00)81959-5 · Cited by 2,790
The STATs of cancer — new molecular targets come of age
Yu, H., & Jove, R. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1275 · Cited by 2,278 · cited 5×
“In sharp contrast to normal cells, STAT3 is constitutively activated in tumor cells [7].”
BackgroundInfluentialSelf-citationZhong, Z., Wen, Z., & Darnell, J. E. (1994) · Science · doi:10.1126/science.8140422 · Cited by 2,070
Chromosome 17 Deletions and p53 Gene Mutations in Colorectal Carcinomas
Baker, S. J., Fearon, E. R., Nigro, J. M., Hamilton, S. R., Preisinger, A. C., Jessup, J. M., vanTuinen, P., Ledbetter, D. H., Barker, D. F., Nakamura, Y., et al. (1989) · Science · doi:10.1126/science.2649981 · Cited by 2,066
Gabrilovich, D. I., Chen, H. L., Girgis, K. R., Cunningham, H. T., Meny, G. M., Nadaf, S., Kavanaugh, D., & Carbone, D. P. (1996) · Nature Medicine · doi:10.1038/nm1096-1096 · Cited by 1,977
Dendritic Cells Induce Peripheral T Cell Unresponsiveness under Steady State Conditions in Vivo
Hawiger, D., Inaba, K., Dorsett, Y., Guo, M., Mahnke, K., Rivera, M., Ravetch, J. V., Steinman, R. M., & Nussenzweig, M. C. (2001) · The Journal of Experimental Medicine · doi:10.1084/jem.194.6.769 · Cited by 1,848
Suppression of Human Colorectal Carcinoma Cell Growth by Wild-Type p53
Baker, S. J., Markowitz, S., Fearon, E. R., Willson, J. K. V., & Vogelstein, B. (1990) · Science · doi:10.1126/science.2144057 · Cited by 1,754
Bowman, T., Garcia, R., Turkson, J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203527 · Cited by 1,743 · cited 1×
“Among the human cancers that display constitutively activated STAT3 are a variety of blood malignancies, including myleoma, leukemias and lymphomas, as well as solid tumors, such as breast, lung, prostate, ovarian cancers and malignant melanomas [10,26].”
BackgroundSelf-citationCatlett-Falcone, R., Landowski, T. H., Oshiro, M. M., Turkson, J., Levitzki, A., Savino, R., Ciliberto, G., Moscinski, L., Fernández-Luna, J. L., Nuñez, G., et al. (1999) · Immunity · doi:10.1016/s1074-7613(00)80011-4 · Cited by 1,638
Self-citationChanging views of the role of matrix metalloproteinases in metastasis
Chambers, A. F., & Matrisian, L. M. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.17.1260 · Cited by 1,588
Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19
Kamijo, T., Zindy, F., Roussel, M. F., Quelle, D. E., Downing, J. R., Ashmun, R. A., Grosveld, G., & Sherr, C. J. (1997) · Cell · doi:10.1016/s0092-8674(00)80452-3 · Cited by 1,566
HIF-1 and mechanisms of hypoxia sensing
Semenza, G. L. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00194-0 · Cited by 1,268
Induction of tolerance by IL-10-treated dendritic cells
Steinbrink, K., Wölfl, M., Jonuleit, H., Knop, J., & Enk, A. H. (1997) · The Journal of Immunology · doi:10.4049/jimmunol.159.10.4772 · Cited by 1,246
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1alpha.
Ravi, R. K., Mookerjee, B., Bhujwalla, Z. M., Sutter, T. R., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · PubMed · Cited by 1,230
Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
Millauer, B., Shawver, L. K., Plate, K. H., Risaui, W., & Ullrich, A. (1994) · Nature · doi:10.1038/367576a0 · Cited by 1,221
Takeda, K., Clausen, B. E., Kaisho, T., Tsujimura, T., Terada, N., Förster, I., & Akira, S. (1999) · Immunity · doi:10.1016/s1074-7613(00)80005-9 · Cited by 1,220
Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis
Niu, G., Wright, K. L., Huang, M., Song, L., Haura, E., Turkson, J., Zhang, S., Wang, T., Sinibaldi, D., Coppola, D., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205260 · Cited by 1,207
Self-citationThe role of STATs in transcriptional control and their impact on cellular function
Bromberg, J., & Darnell, J. E. (2000) · Oncogene · doi:10.1038/sj.onc.1203476 · Cited by 1,201 · cited 3×
“STAT proteins are both cytoplasmic signaling molecules and nuclear transcription factors that activate diverse genes [3,5].”
BackgroundTranscription factors as targets for cancer therapy
Darnell, J. E. (2002) · Nature Reviews Cancer · doi:10.1038/nrc906 · Cited by 1,194 · cited 1×
“Because a wide array of oncogenic/angiogenic proteins converge upon a limited set of nuclear transcription factors, the final ‘switches’ determining gene expression patterns and ultimately leading to malignancy [139], targeting a single transcription factor such as STAT3 potentially neutralizes the oncogenic potential…”
BackgroundHirano, T., Ishihara, K., & Hibi, M. (2000) · Oncogene · doi:10.1038/sj.onc.1203551 · Cited by 1,190
Buettner, R., Mora, L. B., & Jove, R. (2002) · PubMed · Cited by 1,185
Self-citationRegulation of the innate and adaptive immune responses by Stat-3 signaling in tumor cells
Wang, T., Niu, G., Kortylewski, M., Burdelya, L., Shain, K., Zhang, S., Bhattacharya, R., Gabrilovich, D., Heller, R., Coppola, D., et al. (2004) · Nature Medicine · doi:10.1038/nm976 · Cited by 1,155
Self-citationBaker, S. J., Preisinger, A. C., Jessup, J. M., Paraskeva, C., Markowitz, S. D., Willson, J. K. V., Hamilton, S. R., & Vogelstein, B. (1990) · PubMed · Cited by 1,063
Regulation of tumor angiogenesis by p53-induced degradation of hypoxia-inducible factor 1α
Ravi, R., Mookerjee, B., Bhujwalla, Z. M., Sutter, C. H., Artemov, D., Zeng, Q., Dillehay, L. E., Madan, A., Semenza, G. L., & Bedi, A. (2000) · Genes & Development · doi:10.1101/gad.14.1.34 · Cited by 967
Enhanced DNA-Binding Activity of a Stat3-Related Protein in Cells Transformed by the Src Oncoprotein
Yu, C.-L., Meyer, D. J., Campbell, G. S., Larner, A. C., Carter-Su, C., Schwartz, J., & Jove, R. (1995) · Science · doi:10.1126/science.7541555 · Cited by 931
Self-citationLevy, D. E., & Lee, C. (2002) · Journal of Clinical Investigation · doi:10.1172/jci15650 · Cited by 810
Does the Immune System See Tumors as Foreign or Self?
Pardoll, D. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141135 · Cited by 753
Levy, D. E., & Lee, C.-K. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215650 · Cited by 734
Yoshikawa, H., Matsubara, K., Qian, G.-S., Jackson, P., Groopman, J. D., Manning, J. E., Harris, C. C., & Herman, J. G. (2001) · Nature Genetics · doi:10.1038/ng0501-29 · Cited by 722
Matrix metalloproteinases in tumour invasion and metastasis
Curran, S., & Murray, G. I. (1999) · The Journal of Pathology · doi:10.1002/(sici)1096-9896(199911)189:3<300::aid-path456>3.0.co;2-c · Cited by 661
Stat3 Activation by Src Induces Specific Gene Regulation and Is Required for Cell Transformation
Turkson, J., Bowman, T., Garcia, R., Caldenhoven, E., De Groot, R. P., & Jove, R. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2545 · Cited by 651
Self-citationSuppressors of cytokine signaling and immunity
Kubo, M., Hanada, T., & Yoshimura, A. (2003) · Nature Immunology · doi:10.1038/ni1012 · Cited by 618
Stat3 Activation Is Required for Cellular Transformation by v- src
Bromberg, J. F., Horvath, C. M., Besser, D., Lathem, W. W., & Darnell, J. E. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.5.2553 · Cited by 614
Axis of evil: molecular mechanisms of cancer metastasis
Bogenrieder, T., & Herlyn, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206757 · Cited by 593
Menetrier-Caux, C., Montmain, G., Dieu, M. C., Bain, C., Favrot, M. C., Caux, C., & Blay, J. Y. (1998) · Blood · doi:10.1182/blood.v92.12.4778 · Cited by 590
Grandis, J. R., Drenning, S. D., Zeng, Q., Watkins, S. C., Melhem, M. F., Endo, S., Johnson, D. E., Huang, L., He, Y., & Kim, J. D. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.8.4227 · Cited by 588
Matrix metal loproteinases and the development of cancer
Coussens, L. M., & Werb, Z. (1996) · Chemistry & Biology · doi:10.1016/s1074-5521(96)90178-7 · Cited by 568
Wei, D., Le, X., Zheng, L., Wang, L., Frey, J. A., Gao, A. C., Peng, Z., Huang, S., Xiong, H. Q., Abbruzzese, J. L., et al. (2003) · Oncogene · doi:10.1038/sj.onc.1206122 · Cited by 558
Regulatory Activity of Autocrine IL-10 on Dendritic Cell Functions
Corinti, S., Albanesi, C., la Sala, A., Pastore, S., & Girolomoni, G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.7.4312 · Cited by 555
Xie, T.-X., Wei, D., Liu, M., Gao, A. C., Ali-Osman, F., Sawaya, R., & Huang, S. (2004) · Oncogene · doi:10.1038/sj.onc.1207383 · Cited by 550
Interleukin-6 promotes cervical tumor growth by VEGF-dependent angiogenesis via a STAT3 pathway
Wei, L.-H., Kuo, M.-L., Chen, C.-A., Chou, C.-H., Lai, K.-B., Lee, C.-N., & Hsieh, C.-Y. (2003) · Oncogene · doi:10.1038/sj.onc.1206226 · Cited by 536
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway
Boccaccio, C., Andò, M., Tamagnone, L., Bardelli, A., Michieli, P., Battistini, C., & Comoglio, P. M. (1998) · Nature · doi:10.1038/34657 · Cited by 519
Grandis, J. R., Drenning, S. D., Chakraborty, A., Zhou, M. Y., Zeng, Q., Pitt, A. S., & Tweardy, D. J. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3785 · Cited by 507
Stat3-mediated Myc expression is required for Src transformation and PDGF-induced mitogenesis
Bowman, T., Broome, M. A., Sinibaldi, D., Wharton, W., Pledger, W. J., Sedivy, J. M., Irby, R., Yeatman, T., Courtneidge, S. A., & Jove, R. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.131568898 · Cited by 488
Self-citationCompromised HOXA5 function can limit p53 expression in human breast tumours
Raman, V., Martensen, S. A., Reisman, D., Evron, E., Odenwald, W. F., Jaffee, E., Marks, J., & Sukumar, S. (2000) · Nature · doi:10.1038/35016125 · Cited by 482
Immune Tolerance After Delivery of Dying Cells to Dendritic Cells In Situ
Liu, K., Iyoda, T., Saternus, M., Kimura, Y., Inaba, K., & Steinman, R. M. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20021215 · Cited by 468
Hyperactivation of STAT3 is involved in abnormal differentiation of dendritic cells in cancer
Nefedova, Y., Huang, M., Kusmartsev, S., Bhattacharya, R., Cheng, P., Salup, R., Jove, R., & Gabrilovich, D. (2004) · The Journal of Immunology · doi:10.4049/jimmunol.172.1.464 · Cited by 464
Self-citationTurkson, J., Ryan, D., Kim, J. S., Zhang, Y., Chen, Z., Haura, E., Laudano, A., Sebti, S., Hamilton, A. D., & Jove, R. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m107527200 · Cited by 448
Self-citationGarcia, R., Yu, C., Hudnall, A. M., Catlett, R., Nelson, K. L., Smithgall, T. E., Fujita, D. J., Ethier, S. P., & Jove, R. (1997) · PubMed · Cited by 441
Self-citationRoles of activated Src and Stat3 signaling in melanoma tumor cell growth
Niu, G., Bowman, T., Huang, M., Shivers, S., Reintgen, D., Daud, A., Chang, A., Kraker, A., Jove, R., & Yu, H. (2002) · Oncogene · doi:10.1038/sj.onc.1205859 · Cited by 432
Self-citation(1996) · Nature Medicine · doi:10.1038/nm1196-1267 · Cited by 429
Synergistic Roles for Pim-1 and c-Myc in STAT3-Mediated Cell Cycle Progression and Antiapoptosis
Shirogane, T., Fukada, T., Muller, J. M. M., Shima, D. T., Hibi, M., & Hirano, T. (1999) · Immunity · doi:10.1016/s1074-7613(00)80145-4 · Cited by 426
Dendritic Cell Function in Vivo during the Steady State: A Role in Peripheral Tolerance
STEINMAN, R. M., HAWIGER, D., LIU, K., BONIFAZ, L., BONNYAY, D., MAHNKE, K., IYODA, T., RAVETCH, J., DHODAPKAR, M., INABA, K., et al. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb06029.x · Cited by 426
AUTOCRINE AND PARACRINE REGULATION BY CYTOKINES AND GROWTH FACTORS IN MELANOMA
Lázár-Molnár, E., Hegyesi, H., Tóth, S., & Falus, A. (2000) · Cytokine · doi:10.1006/cyto.1999.0614 · Cited by 416
Onishi, M., Nosaka, T., Misawa, K., Mui, A. L.-F., Gorman, D., McMahon, M., Miyajima, A., & Kitamura, T. (1998) · Molecular and Cellular Biology · doi:10.1128/mcb.18.7.3871 · Cited by 412
Src family protein tyrosine kinases: cooperating with growth factor and adhesion signaling pathways
Parsons, J. T., & Parsons, S. J. (1997) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(97)80062-2 · Cited by 392
Welte, T., Zhang, S. S. M., Wang, T., Zhang, Z., Hesslein, D. G. T., Yin, Z., Kano, A., Iwamoto, Y., Li, E., Craft, J. E., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237137100 · Cited by 381
SOCS-3 is frequently silenced by hypermethylation and suppresses cell growth in human lung cancer
He, B., You, L., Uematsu, K., Zang, K., Xu, Z., Lee, A. Y., Costello, J. F., McCormick, F., & Jablons, D. M. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2232790100 · Cited by 380
A Critical Role for Stat3 Signaling in Immune Tolerance
Cheng, F., Wang, H.-W., Cuenca, A., Huang, M., Ghansah, T., Brayer, J., Kerr, W. G., Takeda, K., Akira, S., Schoenberger, S. P., et al. (2003) · Immunity · doi:10.1016/s1074-7613(03)00232-2 · Cited by 377
Self-citationMasuda, M., Suzui, M., Yasumatu, R., Nakashima, T., Kuratomi, Y., Azuma, K., Tomita, K., Komiyama, S., & Weinstein, I. B. (2002) · PubMed · Cited by 376
ErbB Receptor-induced Activation of Stat Transcription Factors Is Mediated by Src Tyrosine Kinases
Olayioye, M. A., Beuvink, I., Horsch, K., Daly, J. M., & Hynes, N. E. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17209 · Cited by 367
Dhodapkar, M. V., & Steinman, R. M. (2002) · Blood · doi:10.1182/blood.v100.1.174 · Cited by 363
Song, L., Turkson, J., Karras, J. G., Jove, R., & Haura, E. B. (2003) · Oncogene · doi:10.1038/sj.onc.1206479 · Cited by 362
Self-citationRas-Independent Growth Factor Signaling by Transcription Factor Tyrosine Phosphorylation
Silvennoinen, O., Schindler, C., Schlessinger, J., & Levy, D. E. (1993) · Science · doi:10.1126/science.8378775 · Cited by 338
Thomas, W. D., & Hersey, P. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2195 · Cited by 326
Analysis of genomic targets reveals complex functions of MYC
Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C., & McMahon, S. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1393 · Cited by 312
Niu, G., Heller, R. F., Catlett-Falcone, R., Coppola, D., Jaroszeski, M. J., Dalton, W. S., Jove, R., & Yu, H. (1999) · PubMed · Cited by 312
Self-citationGalm, O., Yoshikawa, H., Esteller, M., Osieka, R., & Herman, J. G. (2003) · Blood · doi:10.1182/blood-2002-06-1735 · Cited by 308
Somatic mutations in the p53 gene and prognosis in breast cancer: a meta-analysis
Pharoah, P. D. P., Day, N. E., & Caldas, C. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690628 · Cited by 308
(1980) · Annals of Internal Medicine · doi:10.7326/0003-4819-92-2-280_1 · Cited by 304
Stat5 Is Essential for the Myelo- and Lymphoproliferative Disease Induced by TEL/JAK2
Schwaller, J., Parganas, E., Wang, D., Cain, D., Aster, J. C., Williams, I. R., Lee, C.-K., Gerthner, R., Kitamura, T., Frantsve, J., et al. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00067-8 · Cited by 303
The genetics of malignant melanoma: lessons from mouse and man
Chin, L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1145 · Cited by 302
Sinibaldi, D., Wharton, W., Turkson, J., Bowman, T., Pledger, W. J., & Jove, R. (2000) · Oncogene · doi:10.1038/sj.onc.1203947 · Cited by 290
Self-citationLou, W., Ni, Z., Dyer, K., Tweardy, D. J., & Gao, A. C. (2000) · The Prostate · doi:10.1002/(sici)1097-0045(20000215)42:3<239::aid-pros10>3.0.co;2-g · Cited by 278
Swope, V. B., Abdel-Malek, Z., Kassem, L. M., & Nordlund, J. J. (1991) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12460991 · Cited by 269
Mutational switch of an IL-6 response to an interferon-γ-like response
Costa-Pereira, A. P., Tininini, S., Strobl, B., Alonzi, T., Schlaak, J. F., Is'harc, H., Gesualdo, I., Newman, S. J., Kerr, I. M., & Poli, V. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.122236099 · Cited by 264
Cytokines and Immune Response in the Tumor Microenvironment
Mocellin, S., Wang, E., & Marincola, F. M. (2001) · Journal of Immunotherapy · doi:10.1097/00002371-200109000-00002 · Cited by 259
Erythropoietin regulates tumour growth of human malignancies
Yasuda, Y. (2003) · Carcinogenesis · doi:10.1093/carcin/bgg060 · Cited by 257 · cited 1×
“However, except for the putative role of STAT5 in the EPO-induced angiogenesis suggested by a study of the xenograft human melanoma model [47], the function”
BackgroundTurkson, J., Kim, J. S., Zhang, S., Yuan, J., Huang, M., Glenn, M., Haura, E., Sebti, S., Hamilton, A. D., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.261.3.3 · Cited by 255
Self-citationShen, Y., Devgan, G., Darnell, J. E., & Bromberg, J. F. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.4.1543 · Cited by 249
Grunstein, J., Roberts, W. G., Mathieu-Costello, O. A., Hanahan, D., & Johnson, R. S. (1999) · PubMed · Cited by 247
Lee, C.-K., Raz, R., Gimeno, R., Gertner, R., Wistinghausen, B., Takeshita, K., DePinho, R. A., & Levy, D. E. (2002) · Immunity · doi:10.1016/s1074-7613(02)00336-9 · Cited by 242
Karni, R., Jove, R., & Levitzki, A. (1999) · Oncogene · doi:10.1038/sj.onc.1202835 · Cited by 242
Self-citationSpiotto, M. T., Yu, P., Rowley, D. A., Nishimura, M. I., Meredith, S. C., Gajewski, T. F., Fu, Y.-X., & Schreiber, H. (2002) · Immunity · doi:10.1016/s1074-7613(02)00480-6 · Cited by 236
Activation of STAT3 by the Hepatitis C Virus Core Protein Leads to Cellular Transformation
Yoshida, T., Hanada, T., Tokuhisa, T., Kosai, K.-I., Sata, M., Kohara, M., & Yoshimura, A. (2002) · The Journal of Experimental Medicine · doi:10.1084/jem.20012127 · Cited by 236
Tumour escape from immune surveillance through dendritic cell inactivation
Vicari, A. P., Caux, C., & Trinchieri, G. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0400 · Cited by 228
Sotomayor, E. M., Borrello, I., Rattis, F.-M., Cuenca, A. G., Abrams, J., Staveley-O'Carroll, K., & Levitsky, H. I. (2001) · Blood · doi:10.1182/blood.v98.4.1070 · Cited by 212
Sombroek, C. C., Stam, A. G. M., Masterson, A. J., Lougheed, S. M., Schakel, M. J. A. G., Meijer, C. J. L. M., Pinedo, H. M., van den Eertwegh, A. J. M., Scheper, R. J., & de Gruijl, T. D. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.168.9.4333 · Cited by 205
Natali, P., Nicotra, M., Di Renzo, M., Prat, M., Bigotti, A., Cavaliere, R., & Comoglio, P. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.422 · Cited by 205
Péguet-Navarro, J., Sportouch, M., Popa, I., Berthier, O., Schmitt, D., & Portoukalian, J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.170.7.3488 · Cited by 203
Requirement of Stat3 signaling for HGF/SF-Met mediated tumorigenesis
Zhang, Y.-W., Wang, L.-M., Jove, R., & Vande Woude, G. F. (2002) · Oncogene · doi:10.1038/sj.onc.1205004 · Cited by 196
Self-citationLevis, M., Tse, K.-F., Smith, B. D., Garrett, E., & Small, D. (2001) · Blood · doi:10.1182/blood.v98.3.885 · Cited by 189
Turkson, J., Zhang, S., Palmer, J., Kay, H., Stanko, J., Mora, L. B., Sebti, S., Yu, H., & Jove, R. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1533.3.12 · Cited by 188
Self-citationYahata, Y., Shirakata, Y., Tokumaru, S., Yamasaki, K., Sayama, K., Hanakawa, Y., Detmar, M., & Hashimoto, K. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301866200 · Cited by 183
木島, 太., Niwa, H., Steinman, R. A., Drenning, S. D., Gooding, W. E., Wentzel, A. L., Xi, S., & Grandis, J. R. (2002) · PubMed · Cited by 177
Lu, C., Vickers, M. F., & Kerbel, R. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.19.9215 · Cited by 170
Dual Inactivation of RB and p53 Pathways in RAS-Induced Melanomas
Bardeesy, N., Bastian, B. C., Hezel, A., Pinkel, D., DePinho, R. A., & Chin, L. (2001) · Molecular and Cellular Biology · doi:10.1128/mcb.21.6.2144-2153.2001 · Cited by 166
VEGF differentially activates STAT3 in microvascular endothelial cells
Bartoli, M., Platt, D. H., Lemtalsi, T., Gu, X., Brooks, S. E., Marrero, M. B., & Caldwell, R. B. (2003) · The FASEB Journal · doi:10.1096/fj.02-1084fje · Cited by 161
Zhou, P., Qian, L., Bieszczad, C. K., Noelle, R. J., Binder, M., Levy, N. B., & Craig, R. W. (1998) · Blood · doi:10.1182/blood.v92.9.3226 · Cited by 157
Kortylewski, M., Heinrich, P. C., Mackiewicz, A. A., Schniertshauer, U., Klingmüller, U., Nakajima, K., Hirano, T., Horn, F., & Behrmann, I. (1999) · Oncogene · doi:10.1038/sj.onc.1202708 · Cited by 152
Self-citationExpression of apoptosis regulators in cutaneous malignant melanoma.
Tang, L., Tron, V. A., Reed, J. C., Mah, K., Krajewska, M., Li, G., Xin Min, Z. H. O. U., Ho, V. C., & Trotter, M. J. (1998) · PubMed · Cited by 152
Huang, M., Dorsey, J. F., Epling‐Burnette, P. K., Nimmanapalli, R., Landowski, T. H., Mora, L. B., Niu, G., Sinibaldi, D., Bai, F., Kraker, A. J., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1206028 · Cited by 146
Self-citationAntiapoptotic bcl-2 and bcl-xL in advanced malignant melanoma
Leiter, U., Schmid, R. M., Kaskel, P., Peter, R. U., & Krähn, G. M. (2000) · Archives of Dermatological Research · doi:10.1007/s004030050479 · Cited by 144
JAK-STAT signaling activated by Abl oncogenes
Danial, N. N., & Rothman, P. B. (2000) · Oncogene · doi:10.1038/sj.onc.1203484 · Cited by 143
Membrane-type metalloproteinases in tumor invasion
Polette, M., & Birembaut, P. L. (1998) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(98)00083-1 · Cited by 129
Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases
Kraehn, G., Utikal, J. S., Udart, M., Greulich, K. M., Bezold, G., Kaskel, P., Leiter, U., & Peter, R. U. (2001) · British Journal of Cancer · doi:10.1054/bjoc.2000.1535 · Cited by 128
Remodeling of the Microenvironment by Aggressive Melanoma Tumor Cells
Hendrix, M. J. C., Seftor, E. A., Kirschmann, D. A., Quaranta, V., & Seftor, R. E. B. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03218.x · Cited by 128
Niu, G., Shain, K. H., Huang, M., Ravi, R. K., Bedi, A., Dalton, W. S., Jove, R., & Yu, H. (2001) · PubMed · Cited by 127
Self-citationBrain metastases in melanoma: Roles of neurotrophins
Denkins, Y. M., Reiland, J., Roy, M., Sinnappah-Kang, N. D., Galjour, J., Murry, B. P., Blust, J., Aucoin, R., & Marchetti, D. (2004) · Neuro-Oncology · doi:10.1215/s115285170300067x · Cited by 126
Deo, D. D., Axelrad, T. W., Robert, E. G., Marcheselli, V., Bazan, N. G., & Hunt, J. D. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110955200 · Cited by 117
Protein tyrosine kinases in malignant melanoma
Easty, D. J., & Bennett, D. C. (2000) · Melanoma Research · doi:10.1097/00008390-200010000-00001 · Cited by 117
Xie, J., Wang, Y., Freeman, M. E., Barlogie, B., & Yi, Q. (2003) · Blood · doi:10.1182/blood-2002-11-3368 · Cited by 110
Bosserhoff, A., Kortylewski, M., Komyod, W., Kauffmann, M.-E., Heinrich, P. C., & Behrmann, I. (2004) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2004.22237.x · Cited by 103
Self-citationbFGF and LIF signaling activates STAT3 in proliferating myoblasts
Megeney, L. A., Perry, R. L., LeCouter, J. E., & Rudnicki, M. A. (1996) · Developmental Genetics · doi:10.1002/(sici)1520-6408(1996)19:2<139::aid-dvg5>3.0.co;2-a · Cited by 93
Chromosome 7 Aneusomy. A Marker for Metastatic Melanoma?
Udart, M., Utikal, J. S., Krähn, G. M., & Peter, R. U. (2001) · Neoplasia · doi:10.1038/sj.neo.7900156 · Cited by 82
Schwartsburd, P. M. (2003) · Cancer and Metastasis Reviews · doi:10.1023/a:1022220219975 · Cited by 81
Nagai, H., Naka, T., Terada, Y., Komazaki, T., Yabe, A., Jin, E.-J., Kawanami, O., Kishimoto, T., Konishi, N., Nakamura, M., et al. (2003) · Journal of Human Genetics · doi:10.1007/s100380300008 · Cited by 78
Yayon, A., Ma, Y., Safran, M., Klagsbrun, M., & Halaban, R. (1997) · Oncogene · doi:10.1038/sj.onc.1201159 · Cited by 78
Udart, M., Utikal, J. S., Krähn, G. M., et al. (2001) · PubMed · doi:10.1038/sj.neo/7900156 · Cited by 74
Boney, C. M., Sekimoto, H., Gruppuso, P. A., & Frackelton, A. R. (2001) · PubMed · Cited by 70
Komazaki, T., Nagai, H., Emi, M., Terada, Y., Yabe, A., Jin, E., Kawanami, O., Konishi, N., Moriyama, Y., Naka, T., et al. (2004) · Japanese Journal of Clinical Oncology · doi:10.1093/jjco/hyh035 · Cited by 64
Lü, C., Sheehan, C., Rak, J. W., Chambers, C. A., Hozumi, N., & Kerbel, R. S. (1996) · PubMed · Cited by 58
Stove, C. P., Derycke, L., Marck, V. V., Mareel, M., Bracke, M., & Stove, V. V. (2003) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2003.12522.x · Cited by 48
Mutated N-ras upregulates Bcl-2 in human melanoma in vitro and in SCID mice
Borner, C., Schlagbauer‐Wadl, H., Fellay, I., Selzer, E., Polterauer, P., & Jansen, B. (1999) · Melanoma Research · doi:10.1097/00008390-199908000-00002 · Cited by 45
Kluger, H. M., DiVito, K. A., Berger, A. J., Halaban, R., Ariyan, S., Camp, R. L., & Rimm, D. L. (2004) · Melanoma Research · doi:10.1097/01.cmr.0000130874.33504.2f · Cited by 42
Wellbrock, C., Geissinger, E., Gómez, A., Fischer, P., Friedrich, K., & Schartl, M. (1998) · Oncogene · doi:10.1038/sj.onc.1201844 · Cited by 40
Tumor-associated macrophages: foe or accomplice of tumors?
Ohno, S., Suzuki, N., Ohno, Y., Inagawa, H., Soma, G., & Inoue, M. (2003) · PubMed · Cited by 38
Tomida, M., & Saito, T. (2003) · Oncogene · doi:10.1038/sj.onc.1207190 · Cited by 37
Altering immune tolerance therapeutically: the power of negative thinking
Prud’homme, G. J. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0803394 · Cited by 20
Cited by
Terzić, J., Grivennikov, S., Karin, E., & Karin, M. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.058 · Cited by 1,974
Crosstalk between cancer and immune cells: role of STAT3 in the tumour microenvironment
Yu, H., Kortylewski, M., & Pardoll, D. (2007) · Nature Reviews Immunology · doi:10.1038/nri1995 · Cited by 1,804
Self-citationDangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer
Grivennikov, S. I., & Karin, M. (2010) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2009.11.005 · Cited by 1,160
Regulation of mTORC1 and its impact on gene expression at a glance
Laplante, M., & Sabatini, D. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125773 · Cited by 667
A Potent and Selective Small-Molecule Degrader of STAT3 Achieves Complete Tumor Regression In Vivo
Bai, L., Zhou, H., Xu, R., Zhao, Y., Chinnaswamy, K., McEachern, D., Chen, J., Yang, C.-Y., Liu, Z., Wang, M., et al. (2019) · Cancer Cell · doi:10.1016/j.ccell.2019.10.002 · Cited by 652
Metadata
- Authors
- Kortylewski, M., Jove, R., & Yu, H.
- Venue
- Cancer and Metastasis Reviews
- Published
- 2005-06
- Volume
- 24
- Issue
- 2
- Pages
- 315-327
- ISSN
- 0167-7659 (ISSN-L)
- 1573-7233
- OpenAlex
- W2041762667
- Cited by
- 280
- References
- 138
- FWCI
- 0.79
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.